CCRAS has developed and commercialized the following two drugs:
1.AYUSH 82 An Anti Diabetic Ayurvedic Formulation
2.AYUSH SG An Anti-Rheumatoid Arthritis preparation.
CCRAS has also undertaken the development of the following coded formulations which are at different phases of drug development:-
i.AYUSH Manas for Mental retardation/cognitive deficit
ii.AYUSH QOL 2C for improving Quality of Life of Cancer patients
iii.AYUSH Rasayan A & B in geriatric health
iv.AYUSH C1 Oil for wound healing
v.AYUSH PJ-7 for Dengue fever
vi.AYUSH M-3 for Migraine
vii.AYUSH SL for Filariasis
viii.AYUSH A for Bronchial Asthma
ix.AYUSH D for Type II Diabetes Mellitus
x.Carctol S for Cancer
xi.AYUSH K1 for Chronic Kidney Diseases
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
